BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang J, Hu Y, Wu N, Wang J. Discovery of Influenza Polymerase PA-PB1 Interaction Inhibitors Using an In Vitro Split-Luciferase Complementation-Based Assay. ACS Chem Biol 2020;15:74-82. [PMID: 31714745 DOI: 10.1021/acschembio.9b00552] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Mcarthur N, Cruz-teran C, Thatavarty A, Reeves GT, Rao BM. Experimental and Analytical Framework for “Mix-and-Read” Assays Based on Split Luciferase. ACS Omega. [DOI: 10.1021/acsomega.2c02319] [Reference Citation Analysis]
2 Hou L, Zhang Y, Ju H, Cherukupalli S, Jia R, Zhang J, Huang B, Loregian A, Liu X, Zhan P. Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins. Acta Pharmaceutica Sinica B 2022;12:1805-24. [DOI: 10.1016/j.apsb.2021.11.018] [Reference Citation Analysis]
3 Chen W, Shao J, Ying Z, Du Y, Yu Y. Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit. Drug Discov Today 2022:S1359-6446(22)00085-X. [PMID: 35247593 DOI: 10.1016/j.drudis.2022.02.024] [Reference Citation Analysis]
4 Azad T, Janse van Rensburg HJ, Morgan J, Rezaei R, Crupi MJF, Chen R, Ghahremani M, Jamalkhah M, Forbes N, Ilkow C, Bell JC. Luciferase-Based Biosensors in the Era of the COVID-19 Pandemic. ACS Nanosci Au 2021;1:15-37. [DOI: 10.1021/acsnanoscienceau.1c00009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mizuta S, Otaki H, Ishikawa T, Makau JN, Yamaguchi T, Fujimoto T, Takakura N, Sakauchi N, Kitamura S, Nono H, Nishi R, Tanaka Y, Takeda K, Nishida N, Watanabe K. Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction. J Med Chem 2021. [PMID: 34905383 DOI: 10.1021/acs.jmedchem.1c01527] [Reference Citation Analysis]
6 Blaszczak E, Lazarewicz N, Sudevan A, Wysocki R, Rabut G. Protein-fragment complementation assays for large-scale analysis of protein-protein interactions. Biochem Soc Trans 2021;49:1337-48. [PMID: 34156434 DOI: 10.1042/BST20201058] [Reference Citation Analysis]
7 Massari S, Desantis J, Nizi MG, Cecchetti V, Tabarrini O. Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions. ACS Infect Dis 2021;7:1332-50. [PMID: 33044059 DOI: 10.1021/acsinfecdis.0c00552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
8 Wang X, Ni D, Liu Y, Lu S. Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions. Front Chem 2021;9:682675. [PMID: 34017824 DOI: 10.3389/fchem.2021.682675] [Reference Citation Analysis]
9 Hu Y, Meng X, Zhang F, Xiang Y, Wang J. The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg Microbes Infect 2021;10:317-30. [PMID: 33560940 DOI: 10.1080/22221751.2021.1888660] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 25.0] [Reference Citation Analysis]
10 Hejdánek J, Radilová K, Pachl P, Hodek J, Machara A, Weber J, Řezáčová P, Konvalinka J, Kožíšek M. structural characterization of the interaction between the C-terminal domain of the influenza polymerase PA subunit and an optimized small peptide inhibitor. Antiviral Res 2021;185:104971. [PMID: 33166574 DOI: 10.1016/j.antiviral.2020.104971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Hu Y, Ma C, Szeto T, Hurst B, Tarbet B, Wang J. Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture. bioRxiv 2020:2020. [PMID: 33140049 DOI: 10.1101/2020.10.30.362335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
12 Boff L, Schreiber A, da Rocha Matos A, Del Sarto J, Brunotte L, Munkert J, Melo Ottoni F, Silva Ramos G, Kreis W, Castro Braga F, José Alves R, Maia de Pádua R, Maria Oliveira Simões C, Ludwig S. Semisynthetic Cardenolides Acting as Antiviral Inhibitors of Influenza A Virus Replication by Preventing Polymerase Complex Formation. Molecules 2020;25:E4853. [PMID: 33096707 DOI: 10.3390/molecules25204853] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ginex T, Luque FJ. Searching for effective antiviral small molecules against influenza A virus: A patent review. Expert Opin Ther Pat 2021;31:53-66. [PMID: 33012213 DOI: 10.1080/13543776.2020.1831471] [Reference Citation Analysis]
14 Wang F, Liu G, Lu Y, Hlasny M, Liu Q, Zhou Y. Acquisition of Avian-Origin PB1 Facilitates Viral RNA Synthesis by the 2009 Pandemic H1N1 Virus Polymerase. Viruses 2020;12:E266. [PMID: 32121117 DOI: 10.3390/v12030266] [Reference Citation Analysis]